| DE19518810A1 (en) | 1995-05-26 | 1996-11-28 | Bayer Ag | Nasal applicator |
| DE69913113T2 (en) | 1998-03-10 | 2004-08-26 | Valois S.A.S. | CONTAINER, METHOD FOR FILLING THIS CONTAINER AND DISPENSER FOR THE POWDER CONTAINED IN THE CONTAINER |
| FR2817847B1 (en) | 2000-12-08 | 2003-03-28 | Tebro | DEVICE FOR DISPENSING FLUID OR POWDERY PRODUCT |
| LU90825B1 (en) | 2001-09-06 | 2003-03-07 | Iee Sarl | Method for the determination of one or more parameters of a seat passenger |
| DK1531794T3 (en) | 2002-06-28 | 2017-08-28 | Civitas Therapeutics Inc | INHALABLE EPINEPHRIN |
| US20050042178A1 (en)* | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder |
| EP1671667A4 (en) | 2003-10-09 | 2013-05-01 | Shin Nippon Biomedical Lab Ltd | Powdery medicine dispensing device for nasal cavity |
| EP2266563A1 (en) | 2009-06-11 | 2010-12-29 | Charité-Universitätsmedizin Berlin (Charité) | Use of opioid receptor antagonists for acute treatment of paraphilic arousal states |
| WO2011013003A2 (en) | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
| EP3248642B1 (en) | 2012-06-28 | 2020-04-08 | The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services | Nasal dry powder delivery system for vaccines and other treatment agents |
| FR3007992B1 (en) | 2013-07-05 | 2018-01-26 | Aptar France Sas | DEVICE FOR DISPENSING FLUID OR PULVERULENT PRODUCT. |
| FR3046552B1 (en) | 2016-01-07 | 2018-02-16 | Aptar France Sas | NASAL POWDER DISTRIBUTION DEVICE. |
| US20180092899A1 (en)* | 2016-09-30 | 2018-04-05 | Merck Sharp & Dohme Corp. | Method of treating acute migraine with cgrp-active compound |
| US20180092839A1 (en) | 2016-10-03 | 2018-04-05 | Lance L. Gooberman | Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders |
| FR3066921B1 (en) | 2017-06-06 | 2022-06-03 | Aptar France Sas | FLUID OR PULVERULENT PRODUCT DISTRIBUTION DEVICE. |
| CA3071552A1 (en) | 2017-08-20 | 2019-02-28 | Formulex Pharma Innovations Ltd. | Dry powder compositions for intranasal delivery |
| US10653690B1 (en) | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| FR3098420B1 (en) | 2019-07-10 | 2021-07-09 | Aptar France Sas | Nasal powder dispenser |
| EP4076395A4 (en)* | 2019-12-17 | 2024-02-07 | Pfizer Ireland Pharmaceuticals | Intranasal pharmaceutical compositions of cgrp inhibitors |
| WO2021234366A1 (en)* | 2020-05-18 | 2021-11-25 | Orexo Ab | New pharmaceutical composition for drug delivery |
| FR3121047B1 (en) | 2021-03-29 | 2023-07-14 | Aptar France Sas | Nasal powder delivery device |
| EP4366804A1 (en) | 2021-07-06 | 2024-05-15 | Iconovo AB | A dry-powder nasal inhaler comprising a casing with a first casing portion and a second casing portion |